Longitude Capital logo

Longitude Capital

North America, California, United States, Menlo Park

Description

Longitude Capital is a venture capital firm that invests in biotechnology and medical technology companies.

Investor Profile

Longitude Capital has made 120 investments, with 12 in the past 12 months and 35% as lead.

Stage Focus

  • Series B (24%)
  • Series C (19%)
  • Series A (18%)
  • Series D (10%)
  • Series Unknown (9%)
  • Private Equity (5%)
  • Post Ipo Equity (5%)
  • Series E (3%)
  • Debt Financing (3%)
  • Series F (2%)

Country Focus

  • United States (90%)
  • Canada (4%)
  • Ireland (3%)
  • Switzerland (2%)
  • France (1%)
  • United Kingdom (1%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Therapeutics
  • Pharmaceutical
  • Medical Device
  • Biopharma
  • Health Diagnostics
  • Manufacturing
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Longitude Capital frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 14
Sofinnova Investments
North America, California, United States, Menlo Park
Co-Investments: 7
Wellington Management
North America, Massachusetts, United States, Boston
Co-Investments: 7
Omega Funds
Europe, Geneve, Switzerland, Geneva
Co-Investments: 11
Kleiner Perkins
North America, California, United States, Menlo Park
Co-Investments: 8
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 7
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 20
Frazier Healthcare Partners
North America, Washington, United States, Seattle
Co-Investments: 11
Rock Springs Capital
North America, Maryland, United States, Baltimore
Co-Investments: 8
Janus Henderson Investors
Europe, England, United Kingdom, London
Co-Investments: 7

Which angels does Longitude Capital often collaborate with?

AB
North America, Tennessee, United States, Nashville
Shared Deals: 1
EM
North America, California, United States, Redwood City
Shared Deals: 1

What are some of recent deals done by Longitude Capital?

Cohere Health

Boston, Massachusetts, United States

Cohere Health is a SaaS company that focuses on improving the efficiency and effectiveness of healthcare delivery.

Consumer SoftwareHealth CareSaaSSoftware
Series CMay 14, 2025
Amount Raised: $90,000,000
CytomX Therapeutics

South San Francisco, California, United States

CytomX Therapeutics is a biotechnology company that focuses on developing proteolytically-activated antibodies.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Post Ipo EquityMay 12, 2025
Amount Raised: $100,000,000
MicroTransponder

Dallas, Texas, United States

MicroTransponder is a medical device company that develops and commercializes neurostimulation devices to treat neurological diseases.

Health CareMedicalMedical Device
Series FMar 12, 2025
Amount Raised: $65,000,000
Helicore Biopharma

San Mateo, California, United States

Helicore Biopharma is a biopharmaceutical company that discovers and develops novel weight-loss therapeutics.

BiopharmaBiotechnologyHealth CareMedicalTherapeutics
Series AJan 28, 2025
Amount Raised: $65,000,000
Aviceda Therapeutics

Cambridge, Massachusetts, United States

Aviceda Therapeutics is a late-stage pre-clinical biotech company developing drugs for treating glyco-immune diseases.

BiotechnologyHealth CareLife SciencePharmaceuticalTherapeutics
Series CJan 7, 2025
Amount Raised: $207,500,000
FIRE1

Dublin, Dublin, Ireland

FIRE1 and is based in Dublin, Ireland, will focus on developing novel therapeutic devices.

BiotechnologyHealth CareMedical DeviceTherapeutics
Series UnknownJan 7, 2025
Amount Raised: $120,000,000
VeraDermics

New Haven, Connecticut, United States

VeraDermics is a dermatology company that creates novel drug delivery mechanisms for a pain-free cure for skin conditions such as warts.

Health CarePharmaceuticalTherapeutics
Series BDec 11, 2024
Amount Raised: $75,000,000
Alentis Therapeutics

Allschwil, Basel-Landschaft, Switzerland

ALENTIS Therapeutics is a Swiss-French biotech company developing novel therapeutics in advanced liver disease and cancer.

BiotechnologyManufacturingPharmaceuticalTherapeutics
Series DNov 12, 2024
Amount Raised: $181,400,000
Alpha9 Theranostics

Vancouver, British Columbia, Canada

Alpha9 Theranostics is a biopharma company that focuses on radiotherapeutics for the treatment of solid and hematologic malignancies.

BiotechnologyMedicalProduct Research
Series COct 23, 2024
Amount Raised: $175,000,000
OrsoBio

Palo Alto, California, United States

OrsoBio is a clinical-stage biopharmaceutical company that develops therapies to treat severe metabolic disorders.

BiopharmaBiotechnologyHealth CareMedicalTherapeutics
Series BSep 6, 2024
Amount Raised: $67,000,000